0001209191-23-028533.txt : 20230510
0001209191-23-028533.hdr.sgml : 20230510
20230510174737
ACCESSION NUMBER: 0001209191-23-028533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230508
FILED AS OF DATE: 20230510
DATE AS OF CHANGE: 20230510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Donnell Niall
CENTRAL INDEX KEY: 0001780235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40315
FILM NUMBER: 23907981
MAIL ADDRESS:
STREET 1: C/O RIVERVEST VENTURE PARTNERS
STREET 2: 101 SOUTH HANLEY RD., STE 1850
CITY: ST. LOUIS
STATE: MO
ZIP: 63105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001637715
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472309515
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: (858) 283-0280
MAIL ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-08
0
0001637715
Reneo Pharmaceuticals, Inc.
RPHM
0001780235
O'Donnell Niall
C/O RENEO PHARMACEUTICALS, INC.
18575 JAMBOREE ROAD, SUITE 275-S
IRVINE
CA
92612
1
0
0
0
0
Common Stock
2023-05-08
4
P
0
125000
8.00
A
2188713
I
By RiverVest Venture Fund IV, L.P.
The shares were purchased in the Issuer's public offering.
The shares held by RiverVest Venture Fund IV, L.P. ("RiverVest Fund IV") are indirectly held by RiverVest Venture Partners IV, L.P., its general partner ("RiverVest Partners IV"). RiverVest Venture Partners IV, LLC is the general partner of RiverVest Partners IV. The individual managers of RiverVest Ventures Partners IV, LLC are Jay Schmelter, John P. McKearn, Ph.D. and the Reporting Person. RiverVest Partners IV, RiverVest Venture Partners IV, LLC and each of the individual managers (including the Reporting Person) share voting and dispositive power with regard to the Company's securities directly held by RiverVest Fund IV.
/s/ Jennifer P. Lam, Attorney-in-Fact
2023-05-10